GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (STU:CUP) » Definitions » Cyclically Adjusted PS Ratio

Chugai Pharmaceutical Co (STU:CUP) Cyclically Adjusted PS Ratio : 13.53 (As of Jun. 01, 2025)


View and export this data going back to . Start your Free Trial

What is Chugai Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2025-06-01), Chugai Pharmaceutical Co's current share price is €45.61. Chugai Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €3.37. Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 13.53.

The historical rank and industry rank for Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:CUP' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.02   Med: 10.18   Max: 18.92
Current: 13.87

During the past years, Chugai Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 18.92. The lowest was 5.02. And the median was 10.18.

STU:CUP's Cyclically Adjusted PS Ratio is ranked worse than
95.8% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs STU:CUP: 13.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Chugai Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2025 was €1.088. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €3.37 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chugai Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.06 10.32 7.87 11.18 13.07

Chugai Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.87 11.38 13.40 13.07 12.44

Competitive Comparison of Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.


;
;

Chugai Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=45.61/3.37
=13.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chugai Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Chugai Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.088/111.1000*111.1000
=1.088

Current CPI (Mar. 2025) = 111.1000.

Chugai Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.540 98.400 0.610
201509 0.577 98.500 0.651
201512 0.604 98.100 0.684
201603 0.581 97.900 0.659
201606 0.657 98.100 0.744
201609 0.608 98.000 0.689
201612 0.649 98.400 0.733
201703 0.633 98.100 0.717
201706 0.622 98.500 0.702
201709 0.622 98.800 0.699
201712 0.667 99.400 0.746
201803 0.686 99.200 0.768
201806 0.652 99.200 0.730
201809 0.657 99.900 0.731
201812 0.730 99.700 0.813
201903 0.747 99.700 0.832
201906 0.827 99.800 0.921
201909 0.968 100.100 1.074
201912 0.890 100.500 0.984
202003 0.917 100.300 1.016
202006 0.947 99.900 1.053
202009 1.019 99.900 1.133
202012 1.013 99.300 1.133
202103 0.793 99.900 0.882
202106 1.014 99.500 1.132
202109 1.347 100.100 1.495
202112 1.523 100.100 1.690
202203 1.677 101.100 1.843
202206 1.011 101.800 1.103
202209 0.965 103.100 1.040
202212 1.863 104.100 1.988
202303 1.326 104.400 1.411
202306 1.040 105.200 1.098
202309 0.993 106.200 1.039
202312 1.060 106.800 1.103
202403 0.884 107.200 0.916
202406 1.107 108.200 1.137
202409 1.209 108.900 1.233
202412 1.140 110.700 1.144
202503 1.088 111.100 1.088

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chugai Pharmaceutical Co  (STU:CUP) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Chugai Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and Actemra for treating rheumatoid arthritis and covid patients.

Chugai Pharmaceutical Co Headlines

No Headlines